英国某中心解剖型股骨柄在全髋关节置换术中的应用经验:平均12年随访假体生存率优异且假体周围骨折率极低
本研究基于前瞻性关节置换数据库,纳入单中心连续1000例使用解剖型股骨柄的初次全髋关节置换术,平均随访12年(10-16年)复查影像,评估假体生存率及假体周围骨折率。全因假体生存率10年为99.1%(95%CI 99.0-99.3%),15年为97.9%(95%CI 97.8-98.0%);股骨柄生存率10年为99.6%(95%CI 99.5-99.7%),15年为98.2%(95%CI 98.1-98.3%);假体周围骨折3例(0.3%),脱位15例(1.5%)。
要点
- 解剖型股骨柄10年全因假体生存率99.1%、15年97.9%,股骨柄生存率10年99.6%、15年98.2%。
- 平均12年随访假体周围骨折3例(0.3%),脱位15例(1.5%)。
- 15年股骨柄无菌性松动生存率100%,无显著骨溶解(透亮线>2mm)病例。
核心结论
- 解剖型股骨柄在初次全髋关节置换术后平均12年随访中表现出优异的假体生存率和极低的假体周围骨折率。
研究设计与样本
- 单中心前瞻性收集的关节置换数据库中共纳入1000例连续使用解剖型股骨柄的初次全髋关节置换术。
- 患者影像于术后平均12年(范围10至16年)复查,以识别翻修手术、脱位或假体周围骨折。
- 手术时平均年龄69岁(范围24至93岁),女性634例(63%),骨关节炎为手术指征者946例(95%)。
主要发现
- 全因全髋关节置换术生存率10年为99.1%(95%CI 99.0-99.3%),15年为97.9%(95%CI 97.8-98.0%)。
- 股骨柄生存率10年为99.6%(95%CI 99.5-99.7%),15年为98.2%(95%CI 98.1-98.3%)。
- 15年股骨柄无菌性松动生存率为100%,未发现显著骨溶解(透亮线>2mm)病例。
- 假体生存率未受患者性别(P = .65)、体重指数(P = .49)、贫困程度(P = .284)、手术指征(P = .33)或美国麻醉医师协会分级(P = .374)的显著影响。
- 平均12年随访期间发现假体周围骨折3例(0.3%),脱位15例(1.5%)。
关键数值与推荐
- 全因全髋关节置换术生存率10年99.1%(95%CI 99.0-99.3%)、15年97.9%(95%CI 97.8-98.0%)。
- 股骨柄生存率10年99.6%(95%CI 99.5-99.7%)、15年98.2%(95%CI 98.1-98.3%)。
- 股骨柄15年无菌性松动生存率100%,无透亮线>2mm的显著骨溶解病例。
- 假体周围骨折3例(0.3%),脱位15例(1.5%),随访平均12年。
- 假体生存率与性别(P = .65)、体重指数(P = .49)、贫困程度(P = .284)、手术指征(P = .33)、美国麻醉医师协会分级(P = .374)均无显著关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As the clinical burden of periprosthetic fractures (PPFs) continues to increase, it has been suggested that the use of anatomical femoral stems may help reduce PPF risk. The primary aim of this study was to determine the survivorship and PPF rate of an anatomical femoral stem in a single center at minimum 10-year follow-up. METHODS: A total of 1,000 consecutive total hip arthroplasties (THAs) performed using an anatomical femoral stem were identified from a prospectively collected arthroplasty database. Patient radiographs were reviewed finally at a mean of 12 years (range, 10 to 16 years) following surgery to identify any revision surgery, dislocations or PPFs. Mean patient age at surgery was 69 years (range, 24 to 93). There were 634 women (63%). Osteoarthritis was the operative indication in 946 patients (95%). RESULTS: All-cause THA survivorship was 99.1% (95% confidence interval (CI), 99.0-99.3%) at 10 years and 97.9% (CI, 97.8 - 98.0%) at 15 years. Stem survivorship at 10 years was 99.6% (CI, 99.5-99.7%) and at 15 years was 98.2% (CI, 98.1-98.3%). The 15-year stem survival for aseptic loosening was 100% with no cases of significant lysis found (lucent line >2mm). Implant survivorship was not significantly impacted by patient sex (P = .65), body mass index (P = .49), deprivation level (P = .284), operative indication (P = .33), or American Society of Anesthesiologists class (P = .374). There were 3 PPFs identified (0.3%) at mean 12-year follow-up and 15 dislocations (1.5%). CONCLUSION: This anatomical femoral stem demonstrated excellent survivorship and negligible PPF rates at mean 12-year follow-up following primary THA.
引用
- Turnbull GS, Akhtar MA, Dunstan ERR, et al. Experience of an Anatomic Femoral Stem in a United Kingdom Center - Excellent Survivorship and Negligible Periprosthetic Fracture Rates at Mean 12 Years Following Primary Total Hip Arthroplasty. J Arthroplasty. 2023. PMID: 37454948. doi:10.1016/j.arth.2023.07.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。